This site uses cookies to store information on your computer. I'm fine with this Cookie information
Follow is on Twitter Like us on Facebook Follow us on Instagram
Covid-19 (Coronavirus)

Information and guidance for public, NHSGGC staff, and community-based services.  Hospital visiting restrictions now in place.

For Staff - Immunosuppressants in pregnant/breastfeeding women and live vaccines in babies

Babies born to mothers who received immunosuppressive biological therapy during pregnancy 

Immunisation with live vaccines should be delayed until 6 months of age in children born to mothers who received immunosuppressive biological therapy* during pregnancy. In practice, this means that children born to mothers who were on immunosuppressive biological therapy during pregnancy will not be eligible to receive rotavirus vaccine (and will need to defer BCG, if indicated, for 6 months). Specialist advice should be sought if there is any doubt as to whether an infant due to receive a live attenuated vaccine may be immunosuppressed due to the mother’s therapy. Contact the PHPU or the consultant specialist who is prescribing the medication. 

See the relevant section in the Rotavirus PGD and the BCG PGD 

Breast-fed babies whose mothers are receiving immunosuppressive biological therapy 

Specialist advice should also be sought for breast-fed babies who require a live vaccine, including MMR, and whose mothers are receiving immunosuppressive biological therapy. Contact the PHPU or the consultant specialist who is prescribing the medication.

 

* e.g. TNFis therapy such as alemtuzumab, ofatumumab, infliximab, adalimumab, certolizumab, and golimumab and non-TFIis therapy include sarilumab, ustekinumab  secukinumab , abatacept, tocilizumab, and rituximab)

Page updated July 2020